SUMMIT THERAPEUTICS INC(NASDAQ:SMMT) stock News

SMMT Latest News, Press Relases and Analysis

All

Press Releases

13 days ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT

14 days ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT

14 days ago - By: The Motley Fool - Mentions: LLY VRTX

3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial Results

15 days ago - By: The Motley Fool

This Healthcare Stock's Revolutionary Drug Could Make Early Investors Rich

18 days ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT

20 days ago - By: Benzinga - Mentions: JAZZ JNJ MRK UNH ...

10 Health Care Stocks Whale Activity In Today's Session

20 days ago - By: Benzinga - Mentions: GLXY RGTI SDM BMNR ...

Johnson & Johnson Raises FY25 Forecast, Joins Rigetti Computing, Unity Software, Brighthouse Financial And Other Big Stocks Moving Higher On Wednesday

22 days ago - By: The Schall Law Firm

SMMT Investors Have Opportunity to Join Summit Therapeutics Inc. Fraud Investigation with the Schall Law Firm

22 days ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeutics Inc. - SMMT

24 days ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT

26 days ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT

a month ago - By: Yahoo Finance - Mentions: AZN 9926

Summit, AstraZeneca (AZN) in Advanced Talks Over $15 billion Oncology Licensing Deal

a month ago - By: Zacks Investment Research - Mentions: AZN BMY MRK

SMMT Stock Gains on Rumored Licensing Talks With AstraZeneca

a month ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT

a month ago - By: Yahoo Finance - Mentions: AZN 9926

Summit Therapeutics Reportedly Makes $15B AstraZeneca Licensing Talks for Lung Cancer Drug

a month ago - By: Yahoo Finance - Mentions: AZN

Why AstraZeneca Stock Got Thumped on Thursday

a month ago - By: Bloomberg

Summit Is in Talks for $15 Billion Partnership With AstraZeneca

a month ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT

a month ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT

a month ago - By: ACCESS Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT

a month ago - By: Summit Therapeutics Inc. - Mentions: RVMD

Revolution Medicines and Summit Therapeutics Enter Into Clinical Collaboration to Evaluate Combinations of Three RAS(ON) Inhibitors With Ivonescimab in RAS Mutant Tumors

a month ago - By: ACCESS Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT

a month ago - By: Yahoo Finance - Mentions: NVDA

H.C. Wainwright Sticks With Bullish Call on Summit Therapeutics, $44 Target

a month ago - By: ACCESS Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT

a month ago - By: ACCESS Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT

a month ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT

2 months ago - By: ACCESS Newswire

SUMMIT THERAPEUTICS INC (SMMT) Stock News

SMMT Latest News, Press Relases and Analysis